Sarah L. Chamlin MDProfessor of Pediatrics and Dermatology, Northwestern University Feinberg School of Medicine; Attending Physician, the Ann and Robert H. Lurie Children’s Hospital of Chicago specializing in Pediatric Dermatology
Sarah L. Chamlin, MD, is a Professor of Pediatrics and Dermatology at Northwestern University Feinberg School of Medicine and an Attending Physician at Lurie Children’s Hospital, specializing in pediatric dermatology. Her clinical interests include hemangiomas and other vascular lesions, hair and nails, and general pediatric dermatology. Her research interests include quality-of-life measurement in children and teens with skin disease and hemangiomas. She is an active member of the Hemangioma Investigator Group.
Sarah L Chamlin, MD, has served as a consultant to Regeneron and Sanofi.
Recent Contributions to PracticeUpdate:
- Safety and Efficacy of Topical Timolol Treatment of Infantile Hemangioma
- Epidemiology and Predisposing Factors for Erythema Toxicum Neonatorum and Transient Neonatal Pustular Melanosis
- Long-Term Treatment of Cutaneous Manifestations of Tuberous Sclerosis Complex With Topical 1% Sirolimus Cream
- Atenolol Versus Propranolol for Treatment of Infantile Hemangiomas During the Proliferative Phase
- New Guidelines Recommend Peanut Introduction at a Younger Age
- Inpatient Financial Burden of Atopic Dermatitis in the US
- AAD 2017 Annual Meeting: Dr. Sarah Chamlin's Take-Aways
- Atenolol Treatment for Infantile Haemangioma
- Rocky Mountain Spotted Fever in Children
- Prenatal Risk Factors for the Development of Infantile Hemangiomas